Drugs / Donor TCR α/β-depleted Graft/ATG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01370213 | Sep 2011 → Apr 2016 | acute myeloid leukemia, myelodysplastic syndrome | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor TCR α/β-depleted Graft/ATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01370213 ↗ |